Literature DB >> 20521154

Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages.

Sanjeev Patel1, Jeffrey L Barron, Mehdi Mirzazedeh, Hugh Gallagher, Steve Hyer, Tom Cantor, William D Fraser.   

Abstract

Vitamin D deficiency is associated with an increased risk of many diseases (skeletal and nonskeletal). Emerging data also associate high concentrations of serum parathyroid hormone (PTH) with morbidity and increased mortality in patients both with and without known chronic kidney disease (CKD). Understanding the relationship between vitamin D and PTH and the determinants of PTH is therefore important. We performed a cross-sectional study of 203 patients with varying stages of CKD randomly recruited from the Renal Unit database at our institution. Detailed case review was performed, and samples of fasting blood were taken for biochemical analyses. We measured standard biochemistry, 25-hydroxyvitamin D (25-OHD), 1,25-OHD, and three PTH measurements [1-84 PTH, total PTH, and derived N-terminal truncated, 7-84 PTH (cPTH)]. Vitamin D deficiency was high, with 86% of patients having 25-OHD levels below 30 ng/ml. Estimated glomerular filtration rate (eGFR) was not associated with 25-OHD levels, whereas 1,25-OHD was lower in those with CKD stage 5 versus stage 4, who were not treated with vitamin D metabolites (18 vs. 65 pg/ml, respectively; P < 0.05). All three PTH measurements increased with worsening eGFR, with this finding being more pronounced in those patients who were not treated with vitamin D metabolites. The slope of the regression line of cPTH on eGFR tended to be steeper, -0.90, compared to -0.81 for total PTH and -0.80 for 1-84 PTH (P = 0.06). The ratio of total PTH to cPTH did decrease significantly through the range of CKD stages (P = 0.03). The determinants of PTH were similar for all three PTH measurements, with eGFR having a strong inverse relationship, with weaker relationships for 25-OHD and ionized calcium on multivariate analyses. We confirm that there is a complex relationship between 25-OHD, eGFR, and PTH. Total PTH, 1-84 PTH, and cPTH increase with increasing CKD stages, with a relatively greater increase in cPTH, although the clinical significance of this finding remains uncertain. The three PTH measurements had similar correlations with the biochemical and clinical variables studied, suggesting that either total PTH or 1-84 PTH can be used in clinical practice when evaluating vitamin D and PTH status.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521154     DOI: 10.1007/s00774-010-0192-1

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  31 in total

1.  Vitamin D insufficiency among free-living healthy young adults.

Authors:  Vin Tangpricha; Elizabeth N Pearce; Tai C Chen; Michael F Holick
Journal:  Am J Med       Date:  2002-06-01       Impact factor: 4.965

2.  Glomerular filtration rate is a major determinant of the relationship between 25-hydroxyvitamin D and parathyroid hormone.

Authors:  S Patel; S Hyer; J Barron
Journal:  Calcif Tissue Int       Date:  2007-04-13       Impact factor: 4.333

3.  Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.

Authors:  Lourdes Craver; Maria Paz Marco; Isabel Martínez; Montserrat Rue; Merce Borràs; Maria Luisa Martín; Felipe Sarró; José Manuel Valdivielso; Elvira Fernández
Journal:  Nephrol Dial Transplant       Date:  2007-01-05       Impact factor: 5.992

4.  Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.

Authors:  J Herberth; A Fahrleitner-Pammer; B Obermayer-Pietsch; P Krisper; H Holzer; H H Malluche; H Dobnig
Journal:  Clin Nephrol       Date:  2006-05       Impact factor: 0.975

5.  Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy.

Authors:  Ian M Godber; Cornelle R Parker; Nigel Lawson; Tony Hitch; Christine J Porter; Simon D Roe; Michael J D Cassidy; David J Hosking
Journal:  Ann Clin Biochem       Date:  2002-05       Impact factor: 2.057

6.  PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.

Authors:  Giorgio Coen; Ermanno Bonucci; Paola Ballanti; Alessandro Balducci; Santo Calabria; Giulia A Nicolai; Maria Stephanie Fischer; Francesca Lifrieri; Micaela Manni; Massimo Morosetti; Eleonora Moscaritolo; Daniela Sardella
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

7.  Parathyroid hormone and large related C-terminal fragments increase at different rates with worsening of renal function in chronic kidney disease patients. A possible indicator of bone turnover status?

Authors:  C Donadio; M Ardini; A Lucchesi; E Donadio; T Cantor
Journal:  Clin Nephrol       Date:  2007-03       Impact factor: 0.975

8.  Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study.

Authors:  Joanne L Carter; Shelagh E O'Riordan; Gillian L Eaglestone; Michael P Delaney; Edmund J Lamb
Journal:  Nephrol Dial Transplant       Date:  2008-06-10       Impact factor: 5.992

9.  Factors associated with elevated or blunted PTH response in vitamin D insufficient adults.

Authors:  O Gunnarsson; O S Indridason; L Franzson; G Sigurdsson
Journal:  J Intern Med       Date:  2008-11-15       Impact factor: 8.989

10.  Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes.

Authors:  David H Smith; Eric S Johnson; Micah L Thorp; Xiuhai Yang; Nancy Neil
Journal:  J Bone Miner Metab       Date:  2009-03-31       Impact factor: 2.626

View more
  21 in total

1.  PILL Series. Vitamin D deficiency.

Authors:  Linsey Utami Gani; Choon How How
Journal:  Singapore Med J       Date:  2015-08       Impact factor: 1.858

2.  Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.

Authors:  Idris Guessous; William McClellan; David Kleinbaum; Viola Vaccarino; Henry Hugues; Olivier Boulat; Pedro Marques-Vidal; Fred Paccaud; Jean-Marc Theler; Jean-Michel Gaspoz; Michel Burnier; Gérard Waeber; Peter Vollenweider; Murielle Bochud
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-21       Impact factor: 8.237

3.  Parathyroid-hormone variance is only marginally explained by a panel of determinants: a cross-sectional study of 909 hip-fracture patients.

Authors:  Marco Di Monaco; Carlotta Castiglioni; Fulvia Vallero; Roberto Di Monaco; Rosa Tappero
Journal:  J Bone Miner Metab       Date:  2013-11-08       Impact factor: 2.626

4.  Increased risk of hip fracture among Japanese hemodialysis patients.

Authors:  Minako Wakasugi; Junichiro James Kazama; Masatomo Taniguchi; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara; Ichiei Narita
Journal:  J Bone Miner Metab       Date:  2013-01-06       Impact factor: 2.626

Review 5.  Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity.

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Bonekey Rep       Date:  2015-06-03

6.  Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction.

Authors:  Fabrice Mac-Way; Linda Azzouz; Christian Noel; Marie-Hélène Lafage-Proust
Journal:  J Bone Miner Metab       Date:  2013-06-21       Impact factor: 2.626

7.  Race-specific associations of 25-hydroxyvitamin D and parathyroid hormone with cardiometabolic biomarkers among US white and black postmenopausal women.

Authors:  Jin Xia; Wanzhu Tu; JoAnn E Manson; Hongmei Nan; Aladdin H Shadyab; Jennifer W Bea; Ting-Yuan D Cheng; Lifang Hou; Yiqing Song
Journal:  Am J Clin Nutr       Date:  2020-08-01       Impact factor: 7.045

Review 8.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

9.  Plasma exchange induces vitamin D deficiency.

Authors:  T F Hiemstra; A Casian; P Boraks; D R Jayne; I Schoenmakers
Journal:  QJM       Date:  2013-10-15

Review 10.  Klotho in Clinical Nephrology: Diagnostic and Therapeutic Implications.

Authors:  Javier A Neyra; Ming Chang Hu; Orson W Moe
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-22       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.